Ordinary Index Rebalancing in the Solactive Diversified Developed Economy Healthcare PR Index | November 2021

In the ordinary rebalance the following composition will be implemented effective open 02.11.2021:

ABBOTT LABORATORIES
ABBVIE INC
AMGEN INC
ARENA PHARMACEUTICALS INC
ASTRAZENECA PLC
BECTON DICKINSON AND CO
BRISTOL-MYERS SQUIBB CO
CHR HANSEN HOLDING AS
CRISPR THERAPEUTICS AG
DANAHER CORP
ELI LILLY & CO
ESSILORLUXOTTICA
FRESENIUS MEDICAL CARE AG & CO KGAA
GILEAD SCIENCES INC
JOHNSON & JOHNSON
KONINKLIJKE PHILIPS NV
LONZA GROUP AG
MEDTRONIC PLC
MERCK & CO. INC.
NOVARTIS AG
NOVO NORDISK A/S
PFIZER INC
ROCHE HOLDING AG
SANOFI SA
SARTORIUS STEDIM BIOTECH SA
SIEMENS HEALTHINEERS AG
STRYKER CORP
THERMO FISHER SCIENTIFIC INC
UNITEDHEALTH GROUP INC
ZOETIS INC